LXEO EPS Estimates
Lexeo Therapeutics, Inc. Common Stock
$3.04
-$0.19(-5.88%)
30
Overall
50
Value
18
Tech
23
Quality
Market Cap
$265.01M
Volume
1.05M
52W Range
$2.98 - $10.99
Target Price
$20.30
LXEO EPS estimates: the consensus estimate for Lexeo Therapeutics, Inc. Common Stock's current fiscal year is -$1.18 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
LXEO EPS Estimates
- EPS estimate, current quarter
- $-0.33
- EPS estimate, next quarter
- $-0.34
- EPS estimate, current year
- $-1.18
- EPS estimate, next year
- $-1.44
- EPS growth, 3-year
- +62.88%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.86 |
| 2024 | $-3.09 |
| 2023 | $-12.40 |
| 2022 | $-36.36 |
| 2021 | $-32.60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LXEO | $3.04 | -5.9% | 1.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Lexeo Therapeutics, Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW